22nd Neuropharmacology Conference: Cognitive Enhancers (NEUR2012)

Venue: Hilton New Orleans Riverside

Location: New Orleans, LA 70130, United States

Event Date/Time: Nov 11, 2012 End Date/Time: Nov 12, 2012
Abstract Submission Date: May 14, 2012
Report as Spam


Cognitive enhancement has become a subject of considerable research and, both in neuroscience and society at large, growing controversy. This satellite meeting will survey progress in the field from attempts to facilitate the substrates of memory and cognition in animal models to clinical studies targeted at major psychiatric disorders. Attendees will accordingly have a first-hand opportunity to learn about the broad spectrum of enhancement research ranging from epigenetics through synaptic plasticity and brain networks to behavior. Individual sessions include both cutting edge work on currently marketed drugs and experiments using novel, mechanism-based compounds. The program will therefore be of interest to those interested in present and future therapeutic prospects for autism, age-related cognitive decline, addiction, and depression. It also directly addresses the possibility of enhancement in normal subjects, a contentious issue that affects much of the neuroscience community.


Two Poydras Street
New Orleans
LA 70130
United States

Additional Information

Sessions will cover the following major topics: • Enhancing brain substrates of cognition: o Plasticity and memory o Cortical systems • Enhancement as a treatment for cognitive disorders: o Aging o Spine dysfunction o Experience and epigenetics o Affective Disorders o Schizophrenia Conference Chairs Gary Lynch, University of California, Irvine, CA, USA Barbara Sahakian, University of Cambridge, UK Conference Organizing Committee Graham Collingridge, University of Bristol, UK (TBC) Jacki Crawley, NIMH, NIH, USA Jeffrey Nye, Johnson & Johnson, USA Keynote Speakers Prof Eric Kandel, Columbia University, NY, USA Prof Richard Morris, University of Edinburgh, UK